浸润性导管癌,Invasive ductal carcinoma
1)Invasive ductal carcinoma浸润性导管癌
1.Expression of Ezrin and Galectin-3 and their clinicopathological significance in breast invasive ductal carcinoma;乳腺浸润性导管癌中Ezrin、Galectin-3的表达及临床病理意义
2.Reproducibility in evaluating immunohistochemical results of HER2 expression in breast invasive ductal carcinoma;乳腺浸润性导管癌HER2免疫组化检测结果判定的重复性研究
3.Expression and clinicopathologic significance of Ki-67 in breast invasive ductal carcinoma;乳腺浸润性导管癌Ki-67表达及其临床病理学意义
英文短句/例句
1.The irregular mass lesion seen here is an infiltrating ductal carcinoma of breast.不规则块状病变是乳腺浸润性导管癌。
2.Expressions of CD24 in Breast Invasive Ductal Carcinoma;CD24在乳腺浸润性导管癌中表达的研究
3.The Diagnostic Value of Infiltrated Mammo-ductal Carcinoma by Molybdenum Target X-ray钼靶CR对浸润性导管癌的诊断价值
4.The Diagnostic Experience in Image of Ninty-six Breast Infiltrating Ductal Carcinoma乳腺浸润性导管癌96例影像诊断体会
5.Analysis of the factors related to prognosis of breast invasive ductal carcinoma乳腺浸润性导管癌预后相关因素分析
6.The Prognosis of Molecular Subtypes in Invasive Ductal Breast Cancer乳腺癌分子分型在浸润性导管癌中的预后研究
7.Expression of PTTG and COX2 in Breast Invasive Ductal Carcinoma and Their Clinical Significance;乳腺浸润性导管癌PTTG及COX2的表达及临床意义
8.Expressions and clinical significance of maspin and uPA in breast cancer乳腺浸润性导管癌中Maspin、uPA的表达及其临床意义
9.Relationship Between Expression of ΔNp73 and Prognosis of Invasive Breast Duct Carcinoma乳腺浸润性导管癌中ΔNp73的表达与预后的关系
10.Expression of HPV16,18E6 and MCM7 proteins in mammary invasive duct carcinomas乳腺浸润性导管癌组织中HPV16、18E6及MCM7蛋白的表达
11.Expression of miR-125b and its clinical significance in invasive ductal carcinoma of the breast cancer乳腺浸润性导管癌中miR-125b的表达及其临床意义
12.Expression of Let-7c in invasive ductal carcinoma of breast cancer and its clinical significanceLet-7c在乳腺浸润性导管癌中的表达及临床意义
13.Expression and clinical significance of EphB4 in breast infiltrating ductal carcinoma:report of 65 casesEphB4在乳腺浸润性导管癌中的表达及意义
14.Study on Angiogenesis in Breast Invasive Ductal Carcinoma and Intraductal Proliferative Lesion;乳腺浸润性导管癌和导管内增生性病变中血管生成的研究
15.Study of the Relationship of PDGF-B and PDGFR-α Expression between the Density of Microvessel and Lymphatic Vessel in Breast Infiltrating Ductal Carcinoma;乳腺浸润性导管癌中PDGF-B、PDGFR-α的表达与微血管、淋巴管密度的关系
16.Expression and significance of cyclooxygenase-2 and vascular endothelial growth factor in invasive ductal carcinoma(IDC) of breast乳腺浸润性导管癌血管内皮生长因子和环氧化酶-2的表达及意义
17.A nest of metastatic infiltrating ductal carcinoma from breast is seen in a dilated lymphatic channel in the lung.肺扩张的淋巴管可见来自乳腺浸润性导管癌转移灶。
18.Role of Transcription Factors Ets1 and Stat3 in Regulating Angiogenesis in Breast Infiltrating Ductal Carcinoma;转录因子Ets1和Stat3在乳腺浸润性导管癌中对血管生成的调控作用
相关短句/例句
infiltrating ductal carcinoma浸润性导管癌
1.Differential proteomic analysis in stage Ⅱ breastinfiltrating ductal carcinoma tissue with negative estrogen receptorER~- Ⅱ期乳腺浸润性导管癌的差异表达蛋白质分析
2.Objective:The aim of this study was to investigate the X-ray features ofinfiltrating ductal carcinoma and to analysis its pathological basis and to rise the level of the preoperative diagnostic accuracy.目的:研究浸润性导管癌的X线表现,分析其病理学基础,以提高乳腺癌手术前的诊断水平。
3.Purpose To detect the expression of matrix metalloproteinase-26(MMP-26) in human benign and malignant breast tissues,to evaluate the relationship of MMP-26 expression ininfiltrating ductal carcinoma(IDC)with clinicopathological parameters and its potential value in tumor progression and to explore the correlation of MMP-26 with estrogen receptor(ER).方法应用免疫组化SP法,检测MMP-26蛋白在正常乳腺组织、乳腺增生症、原位癌和乳腺浸润性导管癌(IDC)中的表达,以及ER在IDC中的表达并进行评分,结果用INSTAT统计软件分析。
3)IDC浸润性导管癌
1.Objective To study the relationship between the expression of p57KIP2 and clinicopathological characteristics in invasive duct carcinoma(IDC).目的研究p57KIP2在乳腺浸润性导管癌(invasive duct carcinoma,IDC)中的表达及与临床病理特征的关系。
2.Objective To study the expression cyclinD1,and p57KIP2in invasive duct carcinoma (IDC) and their clinical significances.目的研究cyclinD1、p57KIP2在乳腺浸润性导管癌(IDC)中的表达及意义。
3.[Background and Objective] Breast cancer is one of the most common malignant tumors in women with 75% of which exhibiting invasive ductal carcinoma (IDC) when diagnosed.乳腺癌的75%表现为浸润性导管癌,目前按病理学进程大致将其发生划分为正常乳腺上皮→增生→不典型增生→原位癌→浸润性癌→转移性癌等几个阶段,但其过程中确切分子机制至今仍不详。
4)Invasive mammary carcinoma导管浸润性癌
5)Breast infiltrative lobular carcinoma浸润性导管癌与小叶癌
6)breast invasive ductal carcinoma乳腺浸润性导管癌
1.The different study of the expression of TSP,MVD and erbB4 gene inbreast invasive ductal carcinoma between Han and Uygur;维吾尔族和汉族乳腺浸润性导管癌TSP、MVD、erbB4表达的差异
2.Expression of Ets-1 and VEGF inbreast invasive ductal carcinoma and its clinical significanceEts-1、VEGF在乳腺浸润性导管癌组织的表达及其临床意义
3.Objective: To investigate the expression of pituitary tumor transfor-ming gene (PTTG), matrix metalloproteinase-14 (MMP-14) and vascular endothelial growth factor-C (VEGF-C) in humanbreast invasive ductal carcinoma.目的：检测乳腺浸润性导管癌与乳腺良性病变组织中垂体瘤转化基因(PTTG)，基质金属蛋白酶-14(MMP-14)和血管内皮生长因子-C(VEGF-C)的表达，探讨它们与乳腺浸润性导管癌淋巴结转移的关系及其临床病理意义。
延伸阅读
膀胱浸润性癌膀胱浸润性癌infiltrating carcinoma of bladder又称“实体性癌”。恶性度高，无乳头，表面不平，有显著坏死及钙盐沉着，溃疡边缘呈结节状，早期向深处浸润，转移较早。
